Equity capital markets

The equity capital markets remain a critical avenue for growth, enabling companies to access funding, drive expansion, and secure their competitive edge. Navigating this dynamic landscape, marked by regulatory complexity and evolving market conditions, demands precise legal guidance and strategic insight. Penningtons Manches Cooper supports businesses and their advisers through every stage of equity capital market transactions, ensuring successful outcomes aligned with their commercial objectives.

Specialist counsel for equity transactions

Our corporate team brings deep expertise to mid-market equity capital market transactions, adeptly advising companies, financial advisers, and brokers on initial public offerings, secondary issues, takeover offers and schemes of arrangement. By focusing primarily on mid-market growth businesses, we are uniquely positioned to understand their specific needs and challenges, helping them achieve robust market positions.

With extensive experience across key sectors, including life sciences, technology, fintech, real estate, and retail, our lawyers deliver tailored, sector-specific advice. This specialist knowledge allows us to provide strategic insights that directly address the regulatory and market dynamics impacting these industries.

Our team is highly experienced in navigating the complexities of listing requirements, and the prospectus and disclosure regime, across each of the UK’s equity markets. We offer clear guidance to ensure compliance and reduce risk, allowing our clients to focus confidently on their growth ambitions. Additionally, we support listed companies in meeting their ongoing obligations, including corporate governance standards and the City Code on Takeovers and Mergers (the Takeover Code).

The team is unique for its practical and commercial approach… We appreciate the team’s deep expertise and ability to deliver clear, actionable advice.

Legal 500

Navigating the regulatory complexities inherent in equity capital market transactions requires a nuanced understanding of financial services legislation. We work closely with our financial services regulatory team, who offer comprehensive guidance on UK and EU financial services laws. Our integrated approach ensures that clients receive seamless support across both transactional and regulatory aspects of the UK’s equity capital markets.

Our practice area team has successfully managed numerous types of equity capital markets transactions, demonstrating our capability to effectively steer clients through complex processes. From IPOs and secondary issues to takeovers and intricate governance and compliance matters, our lawyers consistently provide insightful and commercially-focused solutions.

How we help our clients

Initial public offerings

Placings, rights issues and other secondary issues

Takeover offers and schemes of arrangement

Private placements

Listing, prospectus, disclosure and transparency rules

Corporate governance

Useful resources

Recent work highlights

Capital raisings

Advising Sirius Real Estate Limited (FTSE 250), an owner of business and industrial parks in Germany and the UK, in connection with two capital raisings (£150 million and £146 million) involving the UK, South Africa, and the US.

Share buyback programme

Representing Nexteq plc (AIM), a technology company, on a share buyback programme and waiver from independent shareholders under Rule 9 of the Takeover Code.

Multiple equity fundraisings

Advising SkinBioTherapeutics plc (AIM) on four equity fundraisings, a convertible loan and a debt fundraising on AIM, most recently in 2024.

Corporate takeover

Supporting Shore Capital as financial adviser and broker to Warpaint London plc (AIM) in connection with its recommended takeover of Brand Architekts plc (AIM).

Take-private offer

Advising Rotala plc (AIM), represented by its independent directors, in connection with a take-private offer by Rotala Group Limited, a newly incorporated vehicle set up by certain senior managers and their connected persons for the purpose of the offer.

Main market IPO

Advising Oxford Cannabinoid Technologies (now Octavian Therapeutics) on its main market IPO, valuing the company at £48 million, the successful defence of a shareholder requisition and subsequent equity fundraisings.

Equity fundraisings

Representing Cavendish Capital Markets (nominated adviser and broker) on two equity fundraisings by Revolution Bars Group plc (AIM).

Share buyback programme

Advising ME Group International plc (FTSE 250) on a share buyback programme and waiver from independent shareholders under Rule 9 of the Takeover Code.

Equity fundraisings

Representing Cavendish Capital Markets (nominated adviser and broker) on two equity fundraisings by Revolution Bars Group plc (AIM).

Share buyback programme

Advising ME Group International plc (FTSE 250) on a share buyback programme and waiver from independent shareholders under Rule 9 of the Takeover Code.

Keep exploring

Contact us

Please complete the short form below to send us your enquiry. We will be in touch shortly with a reply.

If you need to speak to someone soon, call:

We will only use the information you provide to handle your enquiry. Please read our privacy policy for more information.